Robert J. Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Latest Publications
- 1 January 2005
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 2 (1) , 47-49
U.S. Regulatory Perspective on the Minimal Clinically Important Difference in Chronic Obstructive Pulmonary Disease
This paper outlines the regulatory issues surrounding the determination and use of minimally clinically important differences (MCID) in assessing measures of outcomes from treatments of chronic obstructive pulmonary disease (COPD). To place this discussion in context, it is important to understand the current state of approved therapies for COPD, as well as newer directions in therapy. This paper discusses the currently available, approved drug therapies for COPD in the United States and how they were approved. This is followed by an overview on the use of MCID for assessing outcomes in therapies for COPD, as well the more general experience with MCID from the U.S. regulatory perspective.
- 1 January 2005
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 2 (1) , 47-49
U.S. Regulatory Perspective on the Minimal Clinically Important Difference in Chronic Obstructive Pulmonary Disease
This paper outlines the regulatory issues surrounding the determination and use of minimally clinically important differences (MCID) in assessing measures of outcomes from treatments of chronic obstructive pulmonary disease (COPD). To place this discussion in context, it is important to understand the current state of approved therapies for COPD, as well as newer directions in therapy. This paper discusses the currently available, approved drug therapies for COPD in the United States and how they were approved. This is followed by an overview on the use of MCID for assessing outcomes in therapies for COPD, as well the more general experience with MCID from the U.S. regulatory perspective.
- 1 April 2003
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 41 (4) , 559-560
FDA “black box” labeling
- 1 April 2003
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 41 (4) , 559-560
FDA “black box” labeling